XML 28 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Registered shares
Additional paid-in capital
Treasury shares
Retained earnings
Accumulated other comprehensive loss
Beginning of the period (in shares) at Mar. 31, 2017   173,106   10,727    
Beginning of the period at Mar. 31, 2017 $ 856,111 $ 30,148 $ 26,596 $ (174,037) $ 1,074,110 $ (100,706)
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard (Note 2) 215,793       208,542 7,251
Purchases of registered shares (in shares)       863    
Purchases of registered shares (30,722)     $ (30,722)    
Sale of shares upon exercise of options and purchase rights (in shares)       (1,527)    
Sale of shares upon exercise of stock options and purchase rights 41,910   21,315 $ 20,595    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,536)    
Issuance of shares upon vesting of restricted stock units (29,813)   (48,291) $ 18,478    
Share-based compensation 44,317   44,317      
Cash dividends (104,248)       (104,248)  
End of the period (in shares) at Mar. 31, 2018   173,106   8,527    
End of the period balance at Mar. 31, 2018 1,050,557 $ 30,148 47,234 $ (165,686) 1,232,316 (93,455)
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard (Note 2) 245,330       257,573 (12,243)
Purchases of registered shares (in shares)       808    
Purchases of registered shares (32,449)     $ (32,449)    
Sale of shares upon exercise of options and purchase rights (in shares)       (575)    
Sale of shares upon exercise of stock options and purchase rights 18,057   10,526 $ 7,531    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,516)    
Issuance of shares upon vesting of restricted stock units (30,770)   (51,572) $ 20,802    
Share-based compensation 50,467   50,467      
Cash dividends (113,971)       (113,971)  
End of the period (in shares) at Mar. 31, 2019   173,106   7,244    
End of the period balance at Mar. 31, 2019 1,176,339 $ 30,148 56,655 $ (169,802) 1,365,036 (105,698)
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard (Note 2) 434,761       449,723 (14,962)
Purchases of registered shares (in shares)       1,251    
Purchases of registered shares (50,437)     $ (50,437)    
Sale of shares upon exercise of options and purchase rights (in shares)       (1,101)    
Sale of shares upon exercise of stock options and purchase rights 22,241   5,582 $ 16,659    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,184)    
Issuance of shares upon vesting of restricted stock units (24,280)   (41,964) $ 17,684    
Share-based compensation 54,824   54,824      
Cash dividends (124,180)       (124,180)  
End of the period (in shares) at Mar. 31, 2020   173,106   6,210    
End of the period balance at Mar. 31, 2020 $ 1,489,268 $ 30,148 $ 75,097 $ (185,896) $ 1,690,579 $ (120,660)